Craft

GC Pharma

Stock Price

₩159 K

2024-10-29

Market Capitalization

₩1.8 T

2024-10-29

Revenue

₩2 T

FY, 2025

GC Pharma Summary

Company Summary

Overview
GC Pharma (formerly known as Green Cross Corporation, 녹십자) is a biopharmaceutical company that delivers protein therapeutics and vaccines. It develops and exports a variety of plasma-derived products, including albumin, immunoglobulin, and antithrombin.
Type
Public
Status
Active
Founded
1967
HQ
Yongin-si, KR | view all locations
Website
http://www.globalgreencross.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Yongin-si, Gyeonggi-do HQ

    Korea (Republic of)

    107 Ihyeon-ro 30-beongil, Giheung-gu

GC Pharma Financials

Summary Financials

Revenue (Q1, 2026)
₩435.5B
Gross profit (Q1, 2026)
₩162.1B
Net income (Q1, 2026)
₩20.1B
Cash (Q1, 2026)
₩40.7B
EBIT (Q1, 2026)
₩41.1B
Enterprise value
$2.7T

Footer menu